These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 10519389

  • 1. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
    Samadder P, Arthur G.
    Cancer Res; 1999 Oct 01; 59(19):4808-15. PubMed ID: 10519389
    [Abstract] [Full Text] [Related]

  • 2. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
    Samadder P, Richards C, Bittman R, Bhullar RP, Arthur G.
    Anticancer Res; 2003 Oct 01; 23(3B):2291-5. PubMed ID: 12894505
    [Abstract] [Full Text] [Related]

  • 3. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.
    Zhou X, Lu X, Richard C, Xiong W, Litchfield DW, Bittman R, Arthur G.
    J Clin Invest; 1996 Aug 15; 98(4):937-44. PubMed ID: 8770865
    [Abstract] [Full Text] [Related]

  • 4. ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells.
    Arthur G, Samadder P, Bittman R.
    Anticancer Res; 2005 Aug 15; 25(1A):95-100. PubMed ID: 15816524
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
    Kosano H, Yasutomo Y, Kugai N, Nagata N, Inagaki H, Tanaka S, Takatani O.
    Cancer Res; 1990 Jun 01; 50(11):3172-5. PubMed ID: 2334912
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
    Kosano H, Takatani O.
    Cancer Res; 1989 Jun 01; 49(11):2868-70. PubMed ID: 2785846
    [Abstract] [Full Text] [Related]

  • 7. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
    Kosano H, Takatani O.
    Cancer Res; 1988 Nov 01; 48(21):6033-6. PubMed ID: 3262419
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ, Olsen RA, Sehgal I, Melder DC, Modest EJ, Powis G.
    Cancer Res; 1990 Aug 01; 50(15):4458-63. PubMed ID: 2369723
    [Abstract] [Full Text] [Related]

  • 9. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
    Zhou X, Lu X, Arthur G.
    Anticancer Res; 1992 Aug 01; 12(5):1659-62. PubMed ID: 1444233
    [Abstract] [Full Text] [Related]

  • 10. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M.
    Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220
    [Abstract] [Full Text] [Related]

  • 11. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F, Daniel LW.
    Cancer Chemother Pharmacol; 1998 Apr 01; 42(4):319-26. PubMed ID: 9744778
    [Abstract] [Full Text] [Related]

  • 12. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
    Lu X, Arthur G.
    Cancer Res; 1992 May 15; 52(10):2813-7. PubMed ID: 1581895
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ.
    Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230
    [Abstract] [Full Text] [Related]

  • 14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 15. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F, Giuliano AE, Law RE, Van Herle AJ.
    Anticancer Res; 2001 Mar 15; 21(1A):413-20. PubMed ID: 11299771
    [Abstract] [Full Text] [Related]

  • 16. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
    Shoji M, Fukuhara T, Winton EF, Berdel WE, Vogler WR.
    Exp Hematol; 1994 Jan 15; 22(1):13-8. PubMed ID: 8282054
    [Abstract] [Full Text] [Related]

  • 17. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.
    Lu X, Arthur G.
    Cancer Res; 1992 May 15; 52(10):2806-12. PubMed ID: 1581894
    [Abstract] [Full Text] [Related]

  • 18. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
    Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2002 Sep 15; 43(9):3091-8. PubMed ID: 12202534
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI, Gallegos A, Dressler LA, Modest EJ, Powis G.
    Cancer Res; 1993 Sep 15; 53(18):4297-302. PubMed ID: 8395981
    [Abstract] [Full Text] [Related]

  • 20. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S, Lunn JA, Santiskulvong C, Rozengurt E.
    Cancer Res; 2003 May 15; 63(10):2379-87. PubMed ID: 12750255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.